logo/base Created with Sketch.

White Papers

Explore our collection of Echosens white papers, featuring expert insights and scientific evidence on liver health, non-invasive assessment, and the use of FibroScan® in clinical practice.

wave

Dr. Jinsong Zhang - From Silent Threat to Clinical Action: Empowering Primary Care to Address Liver Disease & Improve Metabolic Outcomes chevron

In this white paper, Dr. Jinsong Zhang explores how integrating non-invasive liver assessment with FibroScan® can help primary care providers detect liver disease earlier, better stratify patient risk, and support more proactive, personalized care.

Discover how real-time liver assessment can help bridge the diagnostic gap, engage patients, and improve long-term cardiometabolic health.

Access the white paper 

Dr. Radhika Vayani - Rethinking Metabolic Health in Everyday Primary Care chevron

In this white paper, Dr. Radhika Vayani explores how integrating FibroScan® into routine visits can help primary care providers detect silent liver disease earlier, assess patient risk, and support more proactive, personalized care.

Discover how non-invasive liver assessment can empower clinicians and patients to make more informed decisions and improve long-term metabolic health.

Access the white paper 

Dr. Alisha Mavis - Small Patients, Big Risk: Pediatric MASLD chevron

In this white paper, pediatric hepatologist Dr. Alisha Mavis explores how recognizing pediatric MASLD earlier and integrating FibroScan® into clinical care can help providers assess risk, monitor disease progression, and support more informed, long-term care.

Discover how non-invasive liver assessment can help clinicians and families better understand liver health and take action earlier.

Access the white paper 

Dr. Martin Grajower - Unlocking Better Patient Outcomes: Why Liver Health Is the Key to Metabolic Wellness chevron

In this white paper, endocrinologist Dr. Martin Grajower explores how proactively addressing liver health with FibroScan® can help clinicians detect disease earlier, personalize care, and improve outcomes across obesity, diabetes, and cardiovascular disease.

Discover how non-invasive liver assessment can strengthen a more proactive approach to metabolic care.

Access the white paper 

The Technology Behind FibroScan: Vibration-Controlled Transient Elastography Explaines chevron

This white paper explores why VCTE® has become a global reference in transient elastography, from measurement reliability and standardization to its advantages over other elastography techniques.

Discover the technology backed by 6,000+ peer-reviewed publications and understand what makes VCTE® a trusted standard in clinical practice.

Access the white paper

The Technology Behind Guided VCTE® chevron

This white paper explores how Guided VCTE® brings greater simplicity and efficiency to liver assessment, with an intuitive scanning experience designed to streamline the exam process.

Discover the technology, its key benefits, and how it can support a more seamless FibroScan® experience.

Access the white paper

FibroScan® Solutions in MASH Clinical Trials chevron

This white paper explores how non-invasive liver assessment with FibroScan® can help accelerate patient enrollment, reduce screen failure rates, and monitor therapeutic response throughout clinical trials.

Discover how Echosens solutions can help optimize trial execution and support the development of new MASH therapies.

Access the white paper